Technology
Autoimmunity BioSolutions – SUCCESS PAGE – May 27, 2026
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once
4MINDS has launched the only AI platform that allows companies to build industry specific language models that are private
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
A networking reception in an informal setting to foster connections and cultivate mutually beneficial relationships
Kick off summer with an evening of relaxation, meaningful connections, and curated spa treatments
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis
The first company to deliver the true cold coffee experience to homes, hotels, restaurants, and every other place where people enjoy coffee
Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure